Afimoxifene Recruiting Phase 2 Trials for Mammographically Dense Breast Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03063619Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast